巨细胞动脉炎患者的死亡率:英国初级保健队列研究
基于英国临床实践研究数据链,纳入1990-2014年新诊断的9778例巨细胞动脉炎(GCA)患者及按年龄、性别、诊所和病史年限随机匹配的非血管炎患者,采用Cox回归估计调整风险比。GCA患者诊断后第一年死亡率升高(调整HR 1.51,95%CI 1.40-1.64),1-5年 marginally 升高(调整HR 1.16,95%CI 1.09-1.23),5年后无显著升高(调整HR 1.06,95%CI 1.00-1.12);诊断时年龄<65岁者第一年死亡风险最高(调整HR 2.32,95%CI 1.60-3.35),性别和队列入组年份未见显著差异。
要点
- GCA患者诊断后第一年全因死亡率升高,调整HR 1.51(95%CI 1.40-1.64)。
- 诊断时年龄<65岁的GCA患者第一年死亡风险最高,调整HR 2.32(95%CI 1.60-3.35)。
- GCA诊断5年后死亡率与非血管炎患者无显著差异,调整HR 1.06(95%CI 1.00-1.12)。
核心结论
- GCA患者在诊断后短期内死亡风险增加,尤其是诊断后第一年,但诊断5年后无增加风险。
- 死亡风险因诊断时年龄而异,诊断时年龄<65岁者第一年死亡率增加更明显,但性别或队列入组年份未见显著差异。
研究设计与样本
- 基于英国临床实践研究数据链的队列研究,纳入1990-2014年新诊断的9778例GCA患者,以及按年龄、性别、诊所和入组前病史年限随机匹配的最多10倍非血管炎患者。
- 采用Cox回归估计GCA患者相对于非血管炎患者的调整风险比(HR),并按年龄、性别和队列入组年份分层分析。
主要发现
- 与非血管炎患者相比,GCA患者诊断后第一年死亡率升高(调整HR 1.51,95%CI 1.40-1.64)。
- GCA患者诊断后1至5年死亡率 marginally 升高(调整HR 1.16,95%CI 1.09-1.23)。
- GCA患者诊断5年后死亡率无显著升高(调整HR 1.06,95%CI 1.00-1.12)。
- 诊断时年龄<65岁的GCA患者第一年死亡风险最高(调整HR 2.32,95%CI 1.60-3.35)。
- 死亡风险按性别或队列入组年份未见显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether giant cell arteritis (GCA) is associated with increased all-cause mortality and whether mortality differs according to age, sex, and calendar year of cohort entry. METHODS: Using the UK-based Clinical Practice Research Datalink, we identified 9,778 newly diagnosed GCA patients from 1990-2014, and up to 10 nonvasculitis patients randomly matched to each case on age, sex, practice, and years of history before cohort entry. We used Cox regression to estimate adjusted hazard ratios (HRs) for mortality of GCA patients in comparison to nonvasculitis patients, then stratified by age, sex, and calendar year of cohort entry. RESULTS: Compared with nonvasculitis patients, GCA patients had increased mortality during the first year following diagnosis (adjusted HR 1.51, 95% confidence interval [95% CI] 1.40-1.64), and marginally increased mortality between 1 and 5 years after the diagnosis (adjusted HR 1.16, 95% CI 1.09-1.23), but not >5 years after the diagnosis (adjusted HR 1.06, 95% CI 1.00-1.12). GCA patients diagnosed before age 65 years had the highest mortality risk during the first year following diagnosis (adjusted HR 2.32, 95% CI 1.60-3.35). The mortality risk did not differ substantially by sex or calendar year of cohort entry. CONCLUSION: GCA patients had an increased risk of mortality during the period shortly after the GCA diagnosis, in particular during the first year, but no increased risk after 5 years postdiagnosis. The mortality risk differed by age with an even greater increased 1-year mortality in those age <65 years at diagnosis, but not by sex or calendar year of cohort entry.
引用
- Li L, Neogi T, Jick S, et al. Mortality in Patients With Giant Cell Arteritis: A Cohort Study in UK Primary Care. Arthritis Care Res (Hoboken). 2018. PMID: 29409137. doi:10.1002/acr.23538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。